MedMe Health vs CrowdStrike
Side-by-side comparison of AI visibility scores, market position, and capabilities
Pharmacy clinical services platform enabling pharmacists to scale vaccinations, testing, and prescribing; Microsoft M12-backed serving 1,100+ Canadian pharmacies for expanded scope of practice.
About
MedMe Health is a pharmacy clinical services platform that helps pharmacists schedule, conduct, document, and bill for clinical services at scale — enabling pharmacies to systematically deliver services including medication prescribing and adaptation, point-of-care testing (COVID, flu, strep), vaccination programs, and chronic condition monitoring appointments, rather than managing these services ad hoc. Founded in the late 2010s in Toronto, Canada and a Y Combinator W21 graduate, MedMe Health is backed by Microsoft's M12 venture fund and has scaled to 1,100+ pharmacies across Canada.\n\nMedMe's platform provides pharmacists with appointment scheduling tools for clinical service bookings (which can be patient-initiated or provider-referred), structured clinical service workflows that guide pharmacists through each service type, documentation templates, and billing integration with provincial health authorities and insurance plans. The platform makes it practical for pharmacy chains and independent pharmacies to operate as clinical service providers at scale — without practice management software, the administrative overhead of offering multiple clinical services is prohibitive.\n\nIn 2025, MedMe Health operates at the intersection of pharmacy technology and primary care expansion — Canadian provincial governments have significantly expanded pharmacist scope of practice, allowing pharmacists to prescribe for minor ailments, adapt medications, and provide more comprehensive care services. MedMe competes with RxNT, PioneerRx, and existing pharmacy management system vendors adding clinical service modules for pharmacy practice management. The expansion of pharmacist scope of practice across Canadian provinces creates strong market tailwinds as pharmacies invest in the technology to capture revenue from newly billable services. The 2025 strategy focuses on deepening provincial billing integrations, growing with pharmacy chains implementing standardized clinical programs, and expanding to US pharmacies as scope of practice policies evolve.
CrowdStrike (CRWD) reported $3.95B ARR in FY2025 (ended Jan). Revenue $3.74B, up 29% YoY. Market cap ~$85B. 8,600+ employees. Austin, TX. AI-native cybersecurity platform. Charlotte AI for threat detection.
About
CrowdStrike is an AI-native cybersecurity company founded in 2011 by George Kurtz, Dmitri Alperovitch, and Gregg Marston and headquartered in Austin, Texas, that built the endpoint detection and response (EDR) category and has since expanded into the broadest cloud-native cybersecurity platform in the industry. The company was founded on the insight that traditional antivirus software — signature-based, retrospective, and endpoint-isolated — could not keep pace with sophisticated adversaries operating at machine speed. CrowdStrike's founding architecture, the Falcon platform, was designed cloud-native from day one: a single lightweight agent on the endpoint feeding a cloud-based AI that learns from trillions of security events across every customer simultaneously. The company trades on Nasdaq under the ticker CRWD.\n\nThe CrowdStrike Falcon platform consolidates more than 28 security modules across endpoint security, identity threat protection, cloud security, next-gen SIEM and log management, threat intelligence, and managed detection and response — all delivered through a single agent and unified console. The AI at the platform's core, Charlotte AI, provides conversational security operations, automated investigation, and AI-generated threat summaries that reduce analyst workload. CrowdStrike's threat intelligence team, Adversary Intelligence, tracks and names nation-state and criminal threat actors globally, giving customers predictive insight into campaigns before they hit their environments.\n\nCrowdStrike reported $3.95 billion in annual recurring revenue (ARR) for FY2025 and total revenue of $3.74 billion, up 29% year over year, with a market capitalization of approximately $85 billion. The company has 8,600+ employees and counts a substantial share of the Fortune 500 and global governments as customers. Despite the July 2024 sensor update incident that caused a significant IT outage affecting millions of Windows systems globally, CrowdStrike's customer retention remained strong — a testament to the platform's depth of integration and the switching costs built into its consolidated architecture.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.